Gastric antisecretory and antiulcer activity of bovine hemoglobin

To investigate gastric antisecretory and gastroprotective activity of bovine hemoglobin (B-Hb) in rats. Adult Albino-Wistar rats were divided into groups of 6 animals each. B-Hb in doses of 100, 300 and 900 mg/kg body weight was tested for gastric acid secretion and antiulcer activity. Gastric secre...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastroenterology : WJG Vol. 19; no. 21; pp. 3291 - 3299
Main Authors Al Asmari, Abdulrahman K, Al Omani, Saud, Elfaki, Ibrahim, Tariq, Mohammad, Al Malki, Ahmed, Al Asmary, Saeed
Format Journal Article
LanguageEnglish
Published United States Baishideng Publishing Group Co., Limited 07.06.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To investigate gastric antisecretory and gastroprotective activity of bovine hemoglobin (B-Hb) in rats. Adult Albino-Wistar rats were divided into groups of 6 animals each. B-Hb in doses of 100, 300 and 900 mg/kg body weight was tested for gastric acid secretion and antiulcer activity. Gastric secretions were measured 6 h after pylorus ligation in rats pretreated with B-Hb. The acidity was measured by titrating gastric contents against 0.01 mol/L NaOH to pH 7. Indomethacin ulcers were produced by oral administration of 30 mg/kg bw in the rats pretreated with B-Hb one hour before indomethacin. Six hours after indomethacin stomach removed and ulcer index was recorded. Ethanol ulcer were produced by 1 mL of ethanol in the rats pretreated with B-Hb 30 min before the ethanol. One hour after ethanol stomach were cut open to score ulcers. Histological examination and analysis of gastric wall mucus, non-protein sulfhydryl groups (NP-SH), and myeloperoxidase (MPO) were carried in gastric tissue following ethanol administration. In control rats pylorus ligation for 6 h resulted in the accumulation of 8.1 ± 0.61 mL of gastric secretion. The treatment of the rats with 100, 300 and 900 mg/kg of B-Hb produced a significant decrease in the volume of gastric secretion 5.6 ± 0.63, 5.5 ± 0.75 and 4.7 ± 0.58 mL respectively as compared to the control group [analysis of variance (ANOVA) F = 4.77, P < 0.05]. The lesion area in the control group was found to be 22.4 ± 3.2 mm(2) six hours after the administration of indomethacin. Treatment of rats with B-Hb at doses of 100 mg/kg (24.3 ± 3.29 mm(2)), 300 mg/kg (16.2 ± 1.45 mm(2)) and 900 mg/kg (12.6 ± 1.85 mm(2)) produced a dose dependent decreased the lesion scores (ANOVA F = 4.50, P < 0.05). The ulcer index following one hour after 1 mL ethanol was 7.1 ± 0.31. Pretreatment of rats with B-Hb at the doses of 100 mg/kg (2.5 ± 0.42), 300 mg/kg (2.1 ± 0.4) and 900 mg/kg (0.7 ± 0.21) significantly inhibited the formation of gastric lesions (ANOVA F = 63.26, P < 0.0001). Histological examination of gastric mucosa following ethanol showed significant lesions in the form of gastric pits with detachment of the surface epithelium; vacuolation of epithelial cells and elongation of microvessels. The changes were dose-dependently attenuated by B-Hb. The treatment of rats with ethanol significantly decreased the Alcian blue binding capacity of gastric wall mucus (480 ± 25.6 μg Alcian blue/g of tissue) as compared to control rats (667 ± 25.8 μg). Pretreatment of rats with B-Hb at the doses of 100 mg/kg (516 ± 31.6 μg/g), 300 mg/kg (558 ± 28.8 μg/g) and 900 mg/kg (654 ± 33.8 μg/g) significantly attenuated ethanol induced depletion of gastric wall mucus (ANOVA F = 8.05, P < 0.005). A significant and dose dependent increase of gastric mucosal NP-SH (ANOVA F = 19.62, P < 0.001) and decrease in MPO activity (ANOVA F = 3.1, P < 0.05) was observed in B-Hb treated rats. B-Hb possesses significant gastric antisecretory and gastroprotective activity against experimentally induced gastric lesion. The gastroprotective effects of B-Hb are accompanied by inhibition of neutrophils activity, reduction of oxidative stress and maintenance of mucosal integrity.
AbstractList AIM: To investigate gastric antisecretory and gastroprotective activity of bovine hemoglobin (B-Hb) in rats. METHODS: Adult Albino-Wistar rats were divided into groups of 6 animals each. B-Hb in doses of 100, 300 and 900 mg/kg body weight was tested for gastric acid secretion and antiulcer activity. Gastric secretions were measured 6 h after pylorus ligation in rats pretreated with B-Hb. The acidity was measured by titrating gastric contents against 0.01 mol/L NaOH to pH 7. Indomethacin ulcers were produced by oral administration of 30 mg/kg bw in the rats pretreated with B-Hb one hour before indomethacin. Six hours after indomethacin stomach removed and ulcer index was recorded. Ethanol ulcer were produced by 1 mL of ethanol in the rats pretreated with B-Hb 30 min before the ethanol. One hour after ethanol stomach were cut open to score ulcers. Histological examination and analysis of gastric wall mucus, non-protein sulfhydryl groups (NP-SH), and myeloperoxidase (MPO) were carried in gastric tissue following ethanol administration. RESULTS: In control rats pylorus ligation for 6 h resulted in the accumulation of 8.1 ± 0.61 mL of gastric secretion. The treatment of the rats with 100, 300 and 900 mg/kg of B-Hb produced a significant decrease in the volume of gastric secretion 5.6 ± 0.63, 5.5 ± 0.75 and 4.7 ± 0.58 mL respectively as compared to the control group [analysis of variance (ANOVA) F = 4.77, P < 0.05]. The lesion area in the control group was found to be 22.4 ± 3.2 mm 2 six hours after the administration of indomethacin. Treatment of rats with B-Hb at doses of 100 mg/kg (24.3 ± 3.29 mm 2 ), 300 mg/kg (16.2 ± 1.45 mm 2 ) and 900 mg/kg (12.6 ± 1.85 mm 2 ) produced a dose dependent decreased the lesion scores (ANOVA F = 4.50, P < 0.05). The ulcer index following one hour after 1 mL ethanol was 7.1 ± 0.31. Pretreatment of rats with B-Hb at the doses of 100 mg/kg (2.5 ± 0.42), 300 mg/kg (2.1 ± 0.4) and 900 mg/kg (0.7 ± 0.21) significantly inhibited the formation of gastric lesions (ANOVA F = 63.26, P < 0.0001). Histological examination of gastric mucosa following ethanol showed significant lesions in the form of gastric pits with detachment of the surface epithelium; vacuolation of epithelial cells and elongation of microvessels. The changes were dose-dependently attenuated by B-Hb. The treatment of rats with ethanol significantly decreased the Alcian blue binding capacity of gastric wall mucus (480 ± 25.6 μg Alcian blue/g of tissue) as compared to control rats (667 ± 25.8 μg). Pretreatment of rats with B-Hb at the doses of 100 mg/kg (516 ± 31.6 μg/g), 300 mg/kg (558 ± 28.8 μg/g) and 900 mg/kg (654 ± 33.8 μg/g) significantly attenuated ethanol induced depletion of gastric wall mucus (ANOVA F = 8.05, P < 0.005). A significant and dose dependent increase of gastric mucosal NP-SH (ANOVA F = 19.62, P < 0.001) and decrease in MPO activity (ANOVA F = 3.1, P < 0.05) was observed in B-Hb treated rats. CONCLUSION: B-Hb possesses significant gastric antisecretory and gastroprotective activity against experimentally induced gastric lesion. The gastroprotective effects of B-Hb are accompanied by inhibition of neutrophils activity, reduction of oxidative stress and maintenance of mucosal integrity.
To investigate gastric antisecretory and gastroprotective activity of bovine hemoglobin (B-Hb) in rats. Adult Albino-Wistar rats were divided into groups of 6 animals each. B-Hb in doses of 100, 300 and 900 mg/kg body weight was tested for gastric acid secretion and antiulcer activity. Gastric secretions were measured 6 h after pylorus ligation in rats pretreated with B-Hb. The acidity was measured by titrating gastric contents against 0.01 mol/L NaOH to pH 7. Indomethacin ulcers were produced by oral administration of 30 mg/kg bw in the rats pretreated with B-Hb one hour before indomethacin. Six hours after indomethacin stomach removed and ulcer index was recorded. Ethanol ulcer were produced by 1 mL of ethanol in the rats pretreated with B-Hb 30 min before the ethanol. One hour after ethanol stomach were cut open to score ulcers. Histological examination and analysis of gastric wall mucus, non-protein sulfhydryl groups (NP-SH), and myeloperoxidase (MPO) were carried in gastric tissue following ethanol administration. In control rats pylorus ligation for 6 h resulted in the accumulation of 8.1 ± 0.61 mL of gastric secretion. The treatment of the rats with 100, 300 and 900 mg/kg of B-Hb produced a significant decrease in the volume of gastric secretion 5.6 ± 0.63, 5.5 ± 0.75 and 4.7 ± 0.58 mL respectively as compared to the control group [analysis of variance (ANOVA) F = 4.77, P < 0.05]. The lesion area in the control group was found to be 22.4 ± 3.2 mm(2) six hours after the administration of indomethacin. Treatment of rats with B-Hb at doses of 100 mg/kg (24.3 ± 3.29 mm(2)), 300 mg/kg (16.2 ± 1.45 mm(2)) and 900 mg/kg (12.6 ± 1.85 mm(2)) produced a dose dependent decreased the lesion scores (ANOVA F = 4.50, P < 0.05). The ulcer index following one hour after 1 mL ethanol was 7.1 ± 0.31. Pretreatment of rats with B-Hb at the doses of 100 mg/kg (2.5 ± 0.42), 300 mg/kg (2.1 ± 0.4) and 900 mg/kg (0.7 ± 0.21) significantly inhibited the formation of gastric lesions (ANOVA F = 63.26, P < 0.0001). Histological examination of gastric mucosa following ethanol showed significant lesions in the form of gastric pits with detachment of the surface epithelium; vacuolation of epithelial cells and elongation of microvessels. The changes were dose-dependently attenuated by B-Hb. The treatment of rats with ethanol significantly decreased the Alcian blue binding capacity of gastric wall mucus (480 ± 25.6 μg Alcian blue/g of tissue) as compared to control rats (667 ± 25.8 μg). Pretreatment of rats with B-Hb at the doses of 100 mg/kg (516 ± 31.6 μg/g), 300 mg/kg (558 ± 28.8 μg/g) and 900 mg/kg (654 ± 33.8 μg/g) significantly attenuated ethanol induced depletion of gastric wall mucus (ANOVA F = 8.05, P < 0.005). A significant and dose dependent increase of gastric mucosal NP-SH (ANOVA F = 19.62, P < 0.001) and decrease in MPO activity (ANOVA F = 3.1, P < 0.05) was observed in B-Hb treated rats. B-Hb possesses significant gastric antisecretory and gastroprotective activity against experimentally induced gastric lesion. The gastroprotective effects of B-Hb are accompanied by inhibition of neutrophils activity, reduction of oxidative stress and maintenance of mucosal integrity.
Author Al Asmari, Abdulrahman K
Tariq, Mohammad
Al Malki, Ahmed
Al Omani, Saud
Elfaki, Ibrahim
Al Asmary, Saeed
Author_xml – sequence: 1
  givenname: Abdulrahman K
  surname: Al Asmari
  fullname: Al Asmari, Abdulrahman K
  email: abdulrahman.alasmari@gmail.com
  organization: Research Center, Prince Sultan Military Medical City, Riyadh 11159, Saudi Arabia. abdulrahman.alasmari@gmail.com
– sequence: 2
  givenname: Saud
  surname: Al Omani
  fullname: Al Omani, Saud
– sequence: 3
  givenname: Ibrahim
  surname: Elfaki
  fullname: Elfaki, Ibrahim
– sequence: 4
  givenname: Mohammad
  surname: Tariq
  fullname: Tariq, Mohammad
– sequence: 5
  givenname: Ahmed
  surname: Al Malki
  fullname: Al Malki, Ahmed
– sequence: 6
  givenname: Saeed
  surname: Al Asmary
  fullname: Al Asmary, Saeed
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23745031$$D View this record in MEDLINE/PubMed
BookMark eNpVkF1LwzAUhoNM3IfeeyX9A61JTtOmN8IYOoWBN3od0nxsGV0zkq6yf2_nVPTqcM7L8x54pmjU-tYgdEtwBmXO7z-266wnVeYoyYBW5AJNKCVVSnmOR2hCMC7TCmg5RtMYtxhTAEav0JgONMNAJmi-lLELTiWy7Vw0KpjOh-Ow6a_LoVEmJFJ1rnfdMfE2qX3vWpNszM6vG1-79hpdWtlEc_M9Z-j96fFt8ZyuXpcvi_kqVVAVXWprWmmrrLZSGwYF5UwyRvKyKrjlxCgJTFqMda7AMKopoVzmOeF5ARqDhhl6OPfuD_XOaGXaLshG7IPbyXAUXjrxP2ndRqx9L6AoCeZkKMDnAhV8jMHYX5ZgcdIpBp1i0CkGneKkc0Du_v78BX78wSfYYXYt
CitedBy_id crossref_primary_10_1016_j_toxrep_2015_11_001
crossref_primary_10_1016_j_jep_2023_116545
crossref_primary_10_1016_S2222_1808_14_60477_1
crossref_primary_10_1002_jsfa_12064
crossref_primary_10_1016_j_alcohol_2016_08_003
ContentType Journal Article
Copyright 2013 Baishideng Publishing Group Co., Limited. All rights reserved. 2013
Copyright_xml – notice: 2013 Baishideng Publishing Group Co., Limited. All rights reserved. 2013
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
5PM
DOI 10.3748/wjg.v19.i21.3291
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2219-2840
EndPage 3299
ExternalDocumentID 10_3748_wjg_v19_i21_3291
23745031
Genre Journal Article
GroupedDBID ---
123
29R
2WC
36B
53G
5VR
8WL
AAKDD
ACGFO
AENEX
AFUIB
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CGR
CHBEP
CIEJG
CS3
CUY
CVF
CW9
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
FA0
FRP
GX1
HYE
M~E
NPM
OK1
P2P
RNS
RPM
TR2
XSB
2B.
2C~
92F
92I
93N
93R
AAYXX
CITATION
EMB
SV3
TCJ
TGQ
WFFXF
5PM
ID FETCH-LOGICAL-c396t-fb29dfcfdfade536285a55147968f81eca35af00d4c3e52d2128a4418463d03d3
IEDL.DBID RPM
ISSN 1007-9327
IngestDate Tue Sep 17 21:13:34 EDT 2024
Fri Aug 23 00:27:18 EDT 2024
Thu May 23 23:18:18 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 21
Keywords Rats
Indomethacin
Bovine hemoglobin
Ethanol
Ischemic injury
Gastric ulcers
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c396t-fb29dfcfdfade536285a55147968f81eca35af00d4c3e52d2128a4418463d03d3
Notes Author contributions: Al Asmari AK designed the study, performed some experiments and assisted in the drafting of the manuscript; Elfaki I performed some experiments and collected the data; Al Malki A analyzed and interpreted the data; Tariq M critically reviewed the manuscript; Al Omani S and Al Asmary S supervised the study, assisted in analysis of the data and drafting the manuscript.
Telephone: +966-1-4777714 Fax: +966-1-4786601
Correspondence to: Dr. Abdulrahman K Al Asmari, Research Center, Prince Sultan Military Medical City, PO Box 7897 (775-S), Riyadh 11159, Saudi Arabia. abdulrahman.alasmari@gmail.com
OpenAccessLink https://doi.org/10.3748/wjg.v19.i21.3291
PMID 23745031
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3671081
crossref_primary_10_3748_wjg_v19_i21_3291
pubmed_primary_23745031
PublicationCentury 2000
PublicationDate 2013-06-07
PublicationDateYYYYMMDD 2013-06-07
PublicationDate_xml – month: 06
  year: 2013
  text: 2013-06-07
  day: 07
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle World journal of gastroenterology : WJG
PublicationTitleAlternate World J Gastroenterol
PublicationYear 2013
Publisher Baishideng Publishing Group Co., Limited
Publisher_xml – name: Baishideng Publishing Group Co., Limited
References 2495237 - Gut. 1989 Feb;30(2):156-60
19341911 - Crit Care Clin. 2009 Apr;25(2):311-24, Table of Contents
3304754 - Clin Invest Med. 1987 May;10(3):251-8
2174037 - J Biol Chem. 1990 Nov 15;265(32):19453-60
4142046 - J Physiol. 1974 Oct;242(2):116P-117P
11437645 - Toxicol Appl Pharmacol. 2001 Jul 1;174(1):17-26
6333880 - Arzneimittelforschung. 1984;34(8):885-90
14578741 - Ann Surg. 2003 Nov;238(5):765-71
2423372 - FEBS Lett. 1986 Jun 9;201(2):291-5
863202 - Gastroenterology. 1977 Jul;73(1):62-5
6138366 - J Clin Invest. 1983 Nov;72(5):1586-93
10749095 - Baillieres Best Pract Res Clin Gastroenterol. 2000 Feb;14(1):147-59
10793064 - Am J Pathol. 2000 May;156(5):1527-35
4973848 - Curr Ther Res Clin Exp. 1969 Jan;11(1):15-21
10773720 - Digestion. 2000;61(3):157-64
7909779 - Gastroenterology. 1994 May;106(5):1199-207
13110094 - Lancet. 1953 Dec 5;265(6797):1170-5
4014462 - Am J Physiol. 1985 Jul;249(1 Pt 1):G137-44
21897223 - Curr Opin Gastroenterol. 2011 Oct;27(6):536-42
8072379 - Life Sci. 1994;55(10):827-37
21419762 - Eur J Pharmacol. 2011 Jun 1;659(2-3):95-101
1485975 - Eur J Cardiothorac Surg. 1992;6(12):649-54; discussion 654
19574491 - Am J Physiol Heart Circ Physiol. 2009 Sep;297(3):H905-10
15772335 - Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1796-801
21889024 - Surg Clin North Am. 2011 Oct;91(5):977-82
6637665 - Agents Actions. 1983 Aug;13(5-6):457-60
11795628 - Artif Cells Blood Substit Immobil Biotechnol. 2001 Nov;29(6):415-25
4514976 - Eur J Pharmacol. 1973 May;22(2):191-5
10904145 - J Ethnopharmacol. 2000 Jul;71(1-2):45-53
8807179 - Can J Anaesth. 1996 Jul;43(7):714-23
1261766 - Gastroenterology. 1976 May;70(5 PT.1):737-41
15046625 - Artif Organs. 2004 Mar;28(3):265-70
11009476 - Am J Physiol Heart Circ Physiol. 2000 Oct;279(4):H1880-9
19038330 - Free Radic Biol Med. 2009 Feb 1;46(3):397-405
6103859 - Gastroenterology. 1980 Jul;79(1):67-71
9516391 - Gastroenterology. 1998 Apr;114(4):706-13
13999462 - J Clin Invest. 1963 Apr;42:581-8
2543095 - Ter Arkh. 1989;61(2):46-8
9473409 - Microvasc Res. 1998 Jan;55(1):54-64
9733607 - J Surg Res. 1998 Jul 1;77(2):187-91
15331427 - Am J Pathol. 2004 Sep;165(3):1045-53
11281181 - Dig Dis Sci. 2001 Feb;46(2):318-30
17031208 - Curr Opin Gastroenterol. 2001 Nov;17(6):489-96
1004116 - Lille Med. 1976 Oct;21(8):662-7
16247187 - J Physiol Pharmacol. 2005 Sep;56 Suppl 5:5-31
6114125 - J Endocrinol. 1981 Jun;89(3):451-6
12199624 - Biomed Pharmacother. 2002 Jul;56(5):247-53
1855678 - Gut. 1991 Jul;32(7):735-9
6276474 - J Invest Dermatol. 1982 Mar;78(3):206-9
9433902 - Free Radic Biol Med. 1998 Jan 15;24(2):269-79
7202371 - Arzneimittelforschung. 1982;32(6):657-63
15782104 - Pancreas. 2005 Apr;30(3):254-9
17906434 - Curr Opin Gastroenterol. 2007 Nov;23(6):595-601
16424069 - J Appl Physiol (1985). 2006 May;100(5):1688-91
2799105 - Respir Physiol. 1989 Jul;77(1):119-34
12092825 - Biosci Biotechnol Biochem. 2002 May;66(5):1116-8
516761 - World J Surg. 1979 Aug 31;3(4):477-86
3258836 - Gastroenterology. 1988 Jun;94(6):1254-62
2311875 - Gastroenterology. 1990 Apr;98(4):909-20
191698 - J Surg Res. 1977 Apr;22(4):357-61
16227339 - Br J Anaesth. 2005 Dec;95(6):737-45
10950107 - Lab Invest. 2000 Aug;80(8):1161-9
9824579 - Gut. 1998 Oct;43(4):512-8
6407523 - Br J Nutr. 1983 May;49(3):401-10
2351301 - Gut. 1990 May;31(5):518-21
4095493 - Scand J Gastroenterol. 1985 Dec;20(10):1191-6
6113043 - Can J Physiol Pharmacol. 1981 May;59(5):468-72
18988905 - Stroke. 2009 Jan;40(1):278-84
7317251 - Br J Anaesth. 1981 Dec;53(12):1325-8
22143256 - Cardiology. 2011;120(2):73-83
3631303 - Am J Physiol. 1987 Sep;253(3 Pt 2):H699-703
19710071 - Br J Anaesth. 2009 Oct;103(4):496-504
3278741 - Biochim Biophys Acta. 1988 Feb 24;947(1):29-52
3252180 - Neuroscience. 1988 Dec;27(3):981-7
16617139 - Am J Physiol Heart Circ Physiol. 2006 Sep;291(3):H1126-37
18617559 - Am J Physiol Gastrointest Liver Physiol. 2008 Sep;295(3):G460-9
890212 - Br J Pharmacol. 1977 Jul;60(3):455-60
References_xml
SSID ssj0023352
Score 2.1500146
Snippet To investigate gastric antisecretory and gastroprotective activity of bovine hemoglobin (B-Hb) in rats. Adult Albino-Wistar rats were divided into groups of 6...
AIM: To investigate gastric antisecretory and gastroprotective activity of bovine hemoglobin (B-Hb) in rats. METHODS: Adult Albino-Wistar rats were divided...
SourceID pubmedcentral
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 3291
SubjectTerms Animals
Anti-Ulcer Agents - pharmacology
Brief
Cattle
Cytoprotection
Disease Models, Animal
Dose-Response Relationship, Drug
Ethanol
Female
Gastric Acid - secretion
Gastric Mucosa - drug effects
Gastric Mucosa - pathology
Gastric Mucosa - secretion
Hemoglobins - pharmacology
Indomethacin
Male
Neutrophils - drug effects
Neutrophils - metabolism
Oxidative Stress - drug effects
Peroxidase - metabolism
Rats
Rats, Wistar
Stomach Ulcer - metabolism
Stomach Ulcer - pathology
Stomach Ulcer - prevention & control
Sulfhydryl Compounds - metabolism
Time Factors
Title Gastric antisecretory and antiulcer activity of bovine hemoglobin
URI https://www.ncbi.nlm.nih.gov/pubmed/23745031
https://pubmed.ncbi.nlm.nih.gov/PMC3671081
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV09b8IwELWAqUvVql_0Sxm6dEhI4ji2R4RKUSWqDkViixx_lFQQEIX27_cuIaisHRPbUvRs6d6L794R8pBIqy3nzLdCgkDhBrsBWu7nQqG5jBGhxELh8Ws6miQvUzZtEdbUwlRJ-zovgnK-CMpiVuVWrha61-SJ9d7GA5pCXBRRr03acEAbib5TWVhEVF1xhtwHcsLru0l0Wen9fH4E35EMijgKaCyxS0wMAyyk0UFY2seiwzzJP4FneEKOd4zR69dfdkpatjwj_WeFDTe0B8AUX0j98LIcnkz1ZjvXdu1hzQK2hvCWzsvxz4H1ZnaxRA-Qojwnk-HT-2Dk77oh-JrKdOO7PJbGaWecMpZRLH1USHe4TIUTkdWKMuXC0CSaWhYbiElCAdkBgkFNSA29IJ1yWdor4gFNoCrWGuQCTQwTiieOhVYpl4jU5rJLHhswslVtepGBWEAMM8AQhLXMAMMMMeySyxqk_cwG0i7hB_DtJ6Cj9eEIbHTlbL3b2Ot_r7whR3Hdr8IP-S3pbNZbewesYZPfV6fkF62TwwM
link.rule.ids 230,315,730,783,787,888,27938,27939,53806,53808
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9tAEB1ReoBLW8RH05biAxcOdtZer3f3iBA0bQniAIibtd6P4pY4iCat1F_fGTuOSG_0aO9asmdszRvPzHsAh7n21kspYq80JijSkRqgl3GlDJHLOMU0DQqPL4rRdf7lVtyugehnYdqmfVvVSXM_SZr6ru2tfJjYYd8nNrwcn_AC46JKhy_gJX6vrOiT9EWeRWNEbZGTyRjhieyqk8SzMvz9_VvyK9VJnaUJzzTpxGS4IBhPVwLTMhqtdko-CT1nr-Gmv-mu4-RHMp9Vif3zD5_js5_qDbxagNHouFvegjXfbMPxJ0NaHjZCm9c_CVVSHR6PXHtmfm_9Y0TjEKQ6EU1DVNFPCR_d-cmU6EXqZgeuz06vTkbxQmghtlwXszhUmXbBBheM84LTVKUhJCV1oYJKvTVcmMCYyy33InMY7pRBHIXYhTvGHd-F9Wba-LcQIQLhJrMWMxGeO6GMzINg3piQq8JXegBHvZXLh45Po8Q8hJxTonMwZ9clOqck5wxgr7P-cmfvqwHIFb8sNxBZ9uoKWrslzV5Y991_X3kAG6Or8Xl5_vni63vYzDpZjJjJD7A-e5z7fQQns-pj-yr-BWhq5PU
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9NAEF3RIKFeaBGFhlLwoRcOttde27t7rAohQBPl0EgRF2u9H40hcaKQgMSvZ8aOo4RjjvauJXvG1rzxzLxHyE0irbacp74VEhIUblAN0HK_EArJZYygEgeFB8OsP06-TtLJntRX3bSvizKoZvOgKqd1b-VyrsO2TywcDe5YBnFRROHSuPCEPIVvloo2Ud_mWjhKVBc6KfcBovCmQolcK-GfH4_B70gGZRwFLJaoFRPDQkpZdBCcdhHpsFtyL_z0zsj39sabrpOfwWZdBPrvf5yORz3ZOXm-BaXebbPlBXliq5fk9rNCTQ_tge3LX4gusR4PR6Y-s5lpu_JwLALVJ7yF8wr8OWG9qZ0vkGakrC7IuPfp4a7vbwUXfM1ktvZdEUvjtDNOGZsynK5UiKi4zIQTkdWKpcpRahLNbBobCHtCAZ4CDMMMZYa9Ip1qUdlL4gESYSrWGjISlphUKJ64lFqlXCIyW8gu-dBaOl82vBo55CPooBwcBLm7zMFBOTqoS143HtjtbP3VJfzAN7sNSJp9uAIWr8mztxZ-c_SV78mz0cdefv9l-O2KnMaNOoZP-VvSWa829howyrp4V7-N_wCfs-d1
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gastric+antisecretory+and+antiulcer+activity+of+bovine+hemoglobin&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Al+Asmari%2C+Abdulrahman+K&rft.au=Al+Omani%2C+Saud&rft.au=Elfaki%2C+Ibrahim&rft.au=Tariq%2C+Mohammad&rft.date=2013-06-07&rft.pub=Baishideng+Publishing+Group+Co.%2C+Limited&rft.issn=1007-9327&rft.volume=19&rft.issue=21&rft.spage=3291&rft.epage=3299&rft_id=info:doi/10.3748%2Fwjg.v19.i21.3291&rft_id=info%3Apmid%2F23745031&rft.externalDBID=PMC3671081
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1007-9327&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1007-9327&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1007-9327&client=summon